<div id="readability-page-1"><p>CanSino Biologics Inc. at its EGM held on November 27, 2025, approved appointment of Mr. Man CHO as an independent non-executive Director of the third session of the Board of Directors and appointment of Ms. Xuefeng JI as an independent non-executive Director of the third session of the Board of Directors. The Board of Directors announced that, at the Board of Directors meeting of the Company held immediately following the EGM, the Board of Directors resolved to adjust the<br/> composition of the committees under the Board of Directors with effect from November 27, 2025, until the expiry of the term of the third session of the Board of Directors. Audit Committee: Mr. Yiu Leung Andy CHEUNG (Chairman); Ms. Xuefeng JI; Mr. Chi Shing LI. Remuneration and Assessment Committee: Mr. Man CHO (Chairman); Mr. Yiu Leung Andy CHEUNG; Ms. Xuefeng JI; Mr. Chi Shing LI; Dr. Xuefeng YU. Nomination Committee: Ms. Xuefeng JI (Chairwoman); Mr. Man CHO; Dr. Xuefeng YU.</p></div>

康希諾

康希諾生物

<p>康希諾生物股份有限公司於 2025 年 11 月 27 日的股東特別大會上任命 Man Cho 和 Xuefeng Ji 為獨立非執行董事，並調整了委員會的組成。變更包括審計、薪酬與考核以及提名委員會的新主席和成員，直至第三屆董事會結束</p>

康希諾生物股份公司任命 Man Cho 和季學峯為獨立非執行董事，並調整委員會的組成